세계의 눈 알레르기 치료 시장 보고서(2025년)

Eye Allergy Therapeutics Global Market Report 2025

US $ 4,490 ￦ 6,324,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,141,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,958,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

눈 알레르기 치료 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년 연평균 성장률(CAGR)은 6.1%로 41억 달러에 달할 전망입니다. 예측 기간 동안 성장의 원동력은 노인 인구 증가, 생물학적 치료법의 채택 확대, 안과 연구에 대한 자금 지원 증가, 안구 알레르기 증상에 대한 인식 증가, 약물 전달 기술의 발전 등에 기인할 것으로 예측됩니다. 이 기간 동안 주요 동향으로는 개인 맞춤형 의료의 발전, 서방형 제제의 혁신, 디지털 진단 도구의 통합, 생물학적 치료의 발전, 새로운 비침습적 치료 접근법 등이 있습니다.

눈 알레르기 유병률 증가는 향후 몇 년 동안 눈 알레르기 치료 시장의 성장을 견인할 것으로 예측됩니다. 눈 알레르기는 면역체계가 알레르겐에 반응하여 눈에 염증과 염증을 유발하여 발생합니다. 눈 알레르기 증가는 환경오염의 악화가 주요 원인으로, 공기 중 알레르겐에 노출될 기회가 증가하여 더 많은 알레르기 반응을 일으킵니다. 눈 알레르기 치료는 염증을 억제하고 가려움증과 충혈을 완화하며 알레르기 반응을 예방함으로써 이러한 알레르기를 관리하고 효과적인 증상 완화를 설명합니다. 예를 들어, 2025년 5월 미국의 생물 의학 자원인 국립의학도서관은 눈 알레르기(OA)가 조사 대상의 49.3%(n=207)를 차지했고, 계절성 알레르기성 결막염(SAC)이 90.3%를 차지했으며, 주로 14세(23.4%)와 여성(58.8%)이 많았다고 보고했습니다. 따라서 눈 알레르기 유병률 증가는 눈 알레르기 치료 시장의 확대에 박차를 가하고 있습니다.

눈 알레르기 치료 시장의 주요 시장 진출기업들은 가려움증 완화 치료제를 포함한 혁신적인 제품에 집중하고 있으며, 빠른 증상 완화, 환자 편의성 향상, 시판 의약품을 통한 접근성 향상에 주력하고 있습니다. 눈 알레르기 가려움증 완화 치료는 특히 알레르기성 눈 반응으로 인한 가려움증을 대상으로 합니다. 예를 들어, 2024년 8월 인도 글렌마크제약(Glenmark Pharmaceuticals Limited)은 1일 2회 복용하는 Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1%(OTC)를 출시하였습니다. 이 제제는 눈의 가려움증, 충혈, 눈물 등의 알레르기성 결막염 증상을 빠르고 지속적으로 개선합니다. 이 OTC 제품은 셀프 케어 제품에 대한 수요 증가에 대응하고, 아이케어 시장에서 소비자의 접근성을 확대하기 위한 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계 성장 분석과 전략 분석 프레임워크

• 세계의 눈 알레르기 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 눈 알레르기 치료 시장 : 성장률 분석
• 세계의 눈 알레르기 치료 시장 실적 : 규모와 성장, 2019-2024년
• 세계의 눈 알레르기 치료 시장 예측 : 규모와 성장, 2024-2029년, 2034년
• 세계의 눈 알레르기 치료 : 전체 시장(TAM)

제6장 시장 세분화

• 세계의 눈 알레르기 치료 시장 : 약제 클래스별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 항히스타민제
• 비만세포 안정제
• 이중 작용제
• 코르티코스테로이드
• 충혈 완화제
• 면역치료
• 기타
• 세계의 눈 알레르기 치료 시장 : 알레르기 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 계절성 알레르기성 결막염(SAC)
• 연중성 알레르기성 결막염(PAC)
• 봄철 각결막염(VKC)
• 아토피성 각결막염(AKC)
• 거대 유두 결막염
• 세계의 눈 알레르기 치료 시장 : 투여 경로별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 국소
• 경구
• 주사
• 안구
• 전신
• 세계의 눈 알레르기 치료 시장 : 유통 채널별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 병원 약국
• 소매 약국
• 온라인 약국
• 기타 채널
• 세계의 눈 알레르기 치료 시장 : 최종사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 병원
• 클리닉
• 홈케어
• 약국
• 연구기관
• 세계의 눈 알레르기 치료 시장 : 항히스타민제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• Olopatadine Ketotifen Emedastine Levocabastine Bepotastine
• 세계의 눈 알레르기 치료 시장 : 비만세포 안정제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• Cromolyn Sodium Nedocromil Lodoxamide Pemirolast
• 세계의 눈 알레르기 치료 시장 : 이중 작용제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• Olopatadine
• Ketotifen Fumarate
• Azelastine
• Alcaftadine
• 세계의 눈 알레르기 치료 시장 : 코르티코스테로이드별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• Loteprednol Etabonate
• Prednisolone Acetate
• Dexamethasone
• Fluorometholone
• 세계의 눈 알레르기 치료 시장 : 충혈 완화제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• Naphazoline
• Tetrahydrozoline
• Oxymetazoline
• Phenylephrine
• 세계의 눈 알레르기 치료 시장 : 면역치료별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 피하 면역치료
• 설하 면역치료
• 알레르겐 특이적 탈감작 점안제
• 세계의 눈 알레르기 치료 시장 : 기타별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 비스테로이드성 항염증제
• 생물제제

제7장 지역별/국가별 분석

• 세계의 눈 알레르기 치료 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 눈 알레르기 치료 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 눈 알레르기 치료 시장 : 경쟁 구도
• 눈 알레르기 치료 시장 : 기업 개요
  • Pfizer Inc.
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd.
  • AbbVie Inc.
  • Bayer AG

제31장 기타 주요 기업 및 혁신 기업

• Novartis AG
• GlaxoSmithKline plc
• Teva Pharmaceutical Industries Limited
• Regeneron Pharmaceuticals Inc.
• Alcon Inc.
• Bausch Health Companies Inc.
• Sun Pharmaceutical Industries Limited
• Hikma Pharmaceuticals plc
• Santen Pharmaceutical Co. Ltd.
• Zydus Lifesciences Limited
• Stallergenes Greer Ltd.
• HAL Allergy B.V.
• Ocular Therapeutix Inc.
• Tarsus Pharmaceuticals Inc.
• Nicox S.A.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 전략

• 눈 알레르기 치료 시장, 2029년 : 새로운 기회를 제공하는 국가
• 눈 알레르기 치료 시장, 2029년 : 새로운 기회를 제공하는 부문
• 눈 알레르기 치료 시장, 2029년 : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

Eye allergy therapeutics are treatments designed to alleviate symptoms caused by allergic reactions in the eyes, such as itching, redness, swelling, and tearing. These treatments work by addressing the allergic response and may involve the use of antihistamines, mast cell stabilizers, or corticosteroids.

The primary drug categories for eye allergy treatments include antihistamines, mast cell stabilizers, dual-action agents, corticosteroids, decongestants, immunotherapy, and others. Antihistamines function by blocking histamine receptors, helping to reduce itching, redness, and swelling linked to allergies. Common types of eye allergies include seasonal allergic conjunctivitis (SAC), perennial allergic conjunctivitis (PAC), vernal keratoconjunctivitis (VKC), atopic keratoconjunctivitis (AKC), and giant papillary conjunctivitis. These medications can be administered through various routes such as topical, oral, injectable, ocular, and systemic methods. Distribution occurs via hospital pharmacies, retail pharmacies, online pharmacies, among other channels. The main end users encompass hospitals, clinics, homecare providers, pharmacies, and research institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The eye allergy therapeutics market research report is one of a series of new reports from The Business Research Company that provides eye allergy therapeutics market statistics, including the eye allergy therapeutics industry global market size, regional shares, competitors with the eye allergy therapeutics market share, detailed eye allergy therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the eye allergy therapeutics industry. This eye allergy therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The eye allergy therapeutics market size has grown strongly in recent years. It will grow from $3.04 billion in 2024 to $3.23 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. Several factors contributed to growth during the historic period, including the increasing prevalence of allergic conjunctivitis, greater awareness of eye allergies, higher levels of urban pollution, improved availability of advanced treatments, and enhancements in healthcare infrastructure.

The eye allergy therapeutics market size is expected to see strong growth in the next few years. It will grow to$4.10 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. Growth in the forecast period is expected to be driven by the expanding elderly population, greater adoption of biologic treatments, increased funding for ophthalmic research, heightened awareness of eye allergy symptoms, and progress in drug delivery technologies. Key trends during this time will include developments in personalized medicine, innovations in sustained-release drug formulations, the integration of digital diagnostic tools, advances in biologic therapies, and new non-invasive treatment approaches.

The increasing prevalence of eye allergies is expected to drive the growth of the eye allergy therapeutics market in the coming years. Eye allergies occur when the immune system reacts to allergens, causing inflammation and irritation in the eyes. The rise in eye allergy cases is largely attributed to worsening environmental pollution, which increases exposure to airborne allergens and triggers more allergic responses. Eye allergy therapeutics help manage these allergies by reducing inflammation, relieving itching and redness, and preventing allergic reactions to offer effective symptom relief. For example, in May 2025, the National Library of Medicine, a US-based biomedical resource, reported that ocular allergy (OA) affected 49.3% (n=207) of cases studied, with seasonal allergic conjunctivitis (SAC) making up 90.3%, primarily among 14-year-olds (23.4%) and females (58.8%). Hence, the growing incidence of eye allergies is fueling the expansion of the eye allergy therapeutics market.

Key players in the eye allergy therapeutics market are focusing on innovative products, including itch relief treatments, to provide quicker symptom relief, improve patient comfort, and increase accessibility through over-the-counter options. Eye allergy itch relief therapeutics specifically target itching caused by allergic eye reactions. For instance, in August 2024, Glenmark Pharmaceuticals Limited, an India-based company, introduced Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC), designed for twice-daily use. This formulation delivers fast and lasting relief from symptoms of allergic conjunctivitis such as itching, redness, and watery eyes. The OTC availability caters to the rising demand for self-care products and broadens consumer access within the eye care market.

In July 2023, Harrow Inc., a US-based ophthalmic pharmaceutical provider, acquired the Canadian and US ophthalmic portfolio from Santen Pharmaceutical Co. Ltd. for an undisclosed amount. This acquisition expanded Harrow's presence in North America and added established eye care brands to its portfolio. The move supports Harrow's ambition to become a leading supplier of comprehensive ophthalmic solutions. Santen Pharmaceutical Co. Ltd. is a Japan-based manufacturer specializing in eye allergy therapeutics.

Major players in the eye allergy therapeutics market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals plc, Santen Pharmaceutical Co. Ltd., Zydus Lifesciences Limited, Stallergenes Greer Ltd., HAL Allergy B.V., Ocular Therapeutix Inc., Tarsus Pharmaceuticals Inc., Nicox S.A.

North America was the largest region in the eye allergy therapeutics market in 2024. The regions covered in eye allergy therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the eye allergy therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The eye allergy therapeutics market consists of sales of artificial tears and lubricants, natural or herbal remedies, and non-steroidal anti-inflammatory drugs. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Eye Allergy Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on eye allergy therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for eye allergy therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The eye allergy therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Antihistamines; Mast Cell Stabilizers; Dual-Action Agents; Corticosteroids; Decongestants; Immunotherapy; Other Drug Classes
• 2) By Allergy Type: Seasonal Allergic Conjunctivitis (SAC); Perennial Allergic Conjunctivitis (PAC); Vernal Keratoconjunctivitis (VKC); Atopic Keratoconjunctivitis (AKC); Giant Papillary Conjunctivitis
• 3) By Route of Administration: Topical; Oral; Injectable; Ocular; Systemic
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Channels
• 5) By End User: Hospitals; Clinics; Homecare Settings; Pharmacies; Research Institutions
• Subsegments:
• 1) By Antihistamines: Olopatadine; Ketotifen; Emedastine; Levocabastine; Bepotastine
• 2) By Mast Cell Stabilizers: Cromolyn Sodium; Nedocromil; Lodoxamide; Pemirolast
• 3) By Dual-action Agents: Olopatadine; Ketotifen Fumarate; Azelastine; Alcaftadine
• 4) By Corticosteroids: Loteprednol Etabonate; Prednisolone Acetate; Dexamethasone; Fluorometholone
• 5) By Decongestants: Naphazoline; Tetrahydrozoline; Oxymetazoline; Phenylephrine
• 6) By Immunotherapy: Subcutaneous Immunotherapy; Sublingual Immunotherapy; Allergen-specific Desensitization Drops
• 7) By Other Drug Classes: Nonsteroidal Anti-inflammatory Drugs; Biologics
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Bayer AG; Novartis AG; GlaxoSmithKline plc; Teva Pharmaceutical Industries Limited; Regeneron Pharmaceuticals Inc.; Alcon Inc.; Bausch Health Companies Inc.; Sun Pharmaceutical Industries Limited; Hikma Pharmaceuticals plc; Santen Pharmaceutical Co. Ltd.; Zydus Lifesciences Limited; Stallergenes Greer Ltd.; HAL Allergy B.V.; Ocular Therapeutix Inc.; Tarsus Pharmaceuticals Inc.; Nicox S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Eye Allergy Therapeutics Market Characteristics

3. Eye Allergy Therapeutics Market Trends And Strategies

4. Eye Allergy Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Eye Allergy Therapeutics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Eye Allergy Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Eye Allergy Therapeutics Market Growth Rate Analysis
• 5.4. Global Eye Allergy Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Eye Allergy Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Eye Allergy Therapeutics Total Addressable Market (TAM)

6. Eye Allergy Therapeutics Market Segmentation

• 6.1. Global Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihistamines
• Mast Cell Stabillizers
• Dual-Action Agents
• Corticosteroids
• Decongestants
• Immunotherapy
• Other Drug Classes
• 6.2. Global Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Seasonal Allergic Conjunctivitis (SAC)
• Perennial Allergic Conjunctivitis (PAC)
• Vernal Keratoconjunctivitis (VKC)
• Atopic Keratoconjunctivitis (AKC)
• Giant Papillary Conjunctivitis
• 6.3. Global Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical
• Oral
• Injectable
• Oculae
• Systemic
• 6.4. Global Eye Allergy Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Channels
• 6.5. Global Eye Allergy Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Homecare Settings
• Pharmacies
• Research Institutions
• 6.6. Global Eye Allergy Therapeutics Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Olopatadine
• Ketotifen
• Emedastine
• Levocabastine
• Bepotastine
• 6.7. Global Eye Allergy Therapeutics Market, Sub-Segmentation Of Mast Cell Stabilizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cromolyn Sodium
• Nedocromil
• Lodoxamide
• Pemirolast
• 6.8. Global Eye Allergy Therapeutics Market, Sub-Segmentation Of Dual-action Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Olopatadine
• Ketotifen Fumarate
• Azelastine
• Alcaftadine
• 6.9. Global Eye Allergy Therapeutics Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Loteprednol Etabonate
• Prednisolone Acetate
• Dexamethasone
• Fluorometholone
• 6.10. Global Eye Allergy Therapeutics Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Naphazoline
• Tetrahydrozoline
• Oxymetazoline
• Phenylephrine
• 6.11. Global Eye Allergy Therapeutics Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Subcutaneous Immunotherapy
• Sublingual Immunotherapy
• Allergen-specific Desensitization Drops
• 6.12. Global Eye Allergy Therapeutics Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nonsteroidal Anti-inflammatory Drugs
• Biologics

7. Eye Allergy Therapeutics Market Regional And Country Analysis

• 7.1. Global Eye Allergy Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Eye Allergy Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Eye Allergy Therapeutics Market

• 8.1. Asia-Pacific Eye Allergy Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Eye Allergy Therapeutics Market

• 9.1. China Eye Allergy Therapeutics Market Overview
• 9.2. China Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Eye Allergy Therapeutics Market

• 10.1. India Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Eye Allergy Therapeutics Market

• 11.1. Japan Eye Allergy Therapeutics Market Overview
• 11.2. Japan Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Eye Allergy Therapeutics Market

• 12.1. Australia Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Eye Allergy Therapeutics Market

• 13.1. Indonesia Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Eye Allergy Therapeutics Market

• 14.1. South Korea Eye Allergy Therapeutics Market Overview
• 14.2. South Korea Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Eye Allergy Therapeutics Market

• 15.1. Western Europe Eye Allergy Therapeutics Market Overview
• 15.2. Western Europe Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Eye Allergy Therapeutics Market

• 16.1. UK Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Eye Allergy Therapeutics Market

• 17.1. Germany Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Eye Allergy Therapeutics Market

• 18.1. France Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Eye Allergy Therapeutics Market

• 19.1. Italy Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Eye Allergy Therapeutics Market

• 20.1. Spain Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Eye Allergy Therapeutics Market

• 21.1. Eastern Europe Eye Allergy Therapeutics Market Overview
• 21.2. Eastern Europe Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Eye Allergy Therapeutics Market

• 22.1. Russia Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Eye Allergy Therapeutics Market

• 23.1. North America Eye Allergy Therapeutics Market Overview
• 23.2. North America Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Eye Allergy Therapeutics Market

• 24.1. USA Eye Allergy Therapeutics Market Overview
• 24.2. USA Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Eye Allergy Therapeutics Market

• 25.1. Canada Eye Allergy Therapeutics Market Overview
• 25.2. Canada Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Eye Allergy Therapeutics Market

• 26.1. South America Eye Allergy Therapeutics Market Overview
• 26.2. South America Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Eye Allergy Therapeutics Market

• 27.1. Brazil Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Eye Allergy Therapeutics Market

• 28.1. Middle East Eye Allergy Therapeutics Market Overview
• 28.2. Middle East Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Eye Allergy Therapeutics Market

• 29.1. Africa Eye Allergy Therapeutics Market Overview
• 29.2. Africa Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Eye Allergy Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Eye Allergy Therapeutics Market Competitive Landscape
• 30.2. Eye Allergy Therapeutics Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Eye Allergy Therapeutics Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. GlaxoSmithKline plc
• 31.3. Teva Pharmaceutical Industries Limited
• 31.4. Regeneron Pharmaceuticals Inc.
• 31.5. Alcon Inc.
• 31.6. Bausch Health Companies Inc.
• 31.7. Sun Pharmaceutical Industries Limited
• 31.8. Hikma Pharmaceuticals plc
• 31.9. Santen Pharmaceutical Co. Ltd.
• 31.10. Zydus Lifesciences Limited
• 31.11. Stallergenes Greer Ltd.
• 31.12. HAL Allergy B.V.
• 31.13. Ocular Therapeutix Inc.
• 31.14. Tarsus Pharmaceuticals Inc.
• 31.15. Nicox S.A.

32. Global Eye Allergy Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Eye Allergy Therapeutics Market

34. Recent Developments In The Eye Allergy Therapeutics Market

35. Eye Allergy Therapeutics Market High Potential Countries, Segments and Strategies

• 35.1 Eye Allergy Therapeutics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Eye Allergy Therapeutics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Eye Allergy Therapeutics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료